Ocimum Biosolutions, a leading provider of Laboratory Information Management System (LIMS) and Bioinformatics solutions, announced that ARIUS Research Inc of Toronto has licensed their Biotracker LIMS solution to enhance their Cancer Research facilities in downtown Toronto. The implementation partner for Ocimum is United Bioinformatica Inc (UBI), Canada.

Biotracker is a multi-platform GLP compliant Laboratory Information Management System. The software enables life sciences labs to keep an accurate track of samples, reagents, instruments, processes and output from the time these samples or resources are acquired, right through to the final stage of research. It comes with a multi-level user configurable security feature. It also provides easy and low-cost instrument and application interfacing. This software is a comprehensive lab information and knowledge management system compliant with GLP and based on guidelines set forth by US FDA 21 CFR Part 11.

Anuradha Acharya, CEO, Ocimum, said, "We at Ocimum realize problems faced by a typical research lab in combining different software tools and also different data types. We expect that Biotracker will be vastly beneficial to ARIUS Research in integrating, maintaining and enhancing data management."

ARIUS is a biotechnology company involved in personalizing cancer therapy through the discovery and development of novel anticancer monoclonal antibodies (MAbs). Established in 1999, the company has built a proprietary technology platform, FunctionFIRST, that rapidly identifies powerful MAbs targeting a variety of cancer indications.

Ocimum is an ISO 9001:2000 certified life sciences contract R&D Company that provides cost-effective customized contract research services and next generation bioinformatics tools & services in the area of genomics, proteomics and laboratory information management (LIMS) for Biotech and Pharmaceutical industry.